MedTrace Logo

Directional Deep Brain Stimulation With Patients With Advanced Parkinson's Disease

NCT05394688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-09-28

No results posted yet for this study

Summary

The aim of the study is to assess the clinical outcome in patients with Parkinson's disease treated with directional deep brain stimulation (dDBS). The patients have been selected for the dDBS treatment by their treating neurologist. The study is a registry-based follow-up study.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Hospital District of Helsinki and Uusimaa

    lead OTHER

Principal Investigators

  • Eero Pekkonen, MD, PhD · Helsinki University Central Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-04-12
Completion
2022-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05394688 on ClinicalTrials.gov